Cysteamine (hydrochloride)

Filters:

Results for "Cysteamine (hydrochloride)_LS 180": 1 gene, 1001 gene sets

Name
ADO Gene 2-aminoethanethiol (cysteamine) dioxygenase Human thiol dioxygenases include cysteine dioxygenase (CDO; MIM 603943) and cysteamine (2-aminoethanethiol) dioxygenase (ADO; EC 1.13.11.19). CDO adds 2 oxygen atoms to free cysteine, whereas ADO adds 2 oxygen atoms to free cysteamine to form hypotaurine (Dominy et al., 2007 [PubMed 17581819]).[supplied by OMIM, Mar 2008]
Cysteamine (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lactate (calcium)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lactate (calcium)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
S-Adenosyl-L-methionine (disulfate tosylate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the S-Adenosyl-L-methionine (disulfate tosylate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Perindopril (erbumine)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Perindopril (erbumine)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Chlorhexidine (diacetate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Chlorhexidine (diacetate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Estrone sulfate (potassium)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Estrone sulfate (potassium)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fostamatinib (disodium hexahydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fostamatinib (disodium hexahydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dapagliflozin ((2S)-1,2-propanediol, hydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dapagliflozin ((2S)-1,2-propanediol, hydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Eflornithine (monohydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Eflornithine (monohydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pasireotide (acetate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pasireotide (acetate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenytoin (sodium)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenytoin (sodium)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lenalidomide (hemihydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lenalidomide (hemihydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Neratinib (maleate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Neratinib (maleate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berbamine (dihydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berbamine (dihydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Atazanavir (sulfate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Atazanavir (sulfate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Indacaterol (maleate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Indacaterol (maleate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benztropine (mesylate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benztropine (mesylate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tofacitinib (citrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Canagliflozin (hemihydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Canagliflozin (hemihydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pitavastatin (Calcium)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pitavastatin (Calcium)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ouabain (Octahydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ouabain (Octahydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Palmatine (chloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Palmatine (chloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Quinidine (15% dihydroquinidine)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Quinidine (15% dihydroquinidine)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vinblastine (sulfate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vinblastine (sulfate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (mesylate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (mesylate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Osimertinib (mesylate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Osimertinib (mesylate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Goserelin (acetate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Goserelin (acetate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lumateperone (tosylate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lumateperone (tosylate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Azithromycin (hydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Azithromycin (hydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benproperine (phosphate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benproperine (phosphate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bisoprolol (hemifumarate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bisoprolol (hemifumarate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rutin (trihydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rutin (trihydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Citalopram (hydrobromide)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Citalopram (hydrobromide)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Thyroxine (sodium salt pentahydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Thyroxine (sodium salt pentahydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bosentan (hydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bosentan (hydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (maleate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (maleate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Selinexor _LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Selinexor _LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fluvoxamine (maleate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fluvoxamine (maleate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Niclosamide (olamine)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Niclosamide (olamine)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Gallic acid (hydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Gallic acid (hydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Belumosudil (mesylate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Belumosudil (mesylate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cloxacillin (sodium)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cloxacillin (sodium)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
LY-2584702 (tosylate salt)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the LY-2584702 (tosylate salt)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sivelestat (sodium tetrahydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sivelestat (sodium tetrahydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berberine (chloride hydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berberine (chloride hydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Mitoxantrone (dihydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Mitoxantrone (dihydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Balsalazide (sodium hydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Balsalazide (sodium hydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cabozantinib (S-malate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cabozantinib (S-malate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Erdafitinib _LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Erdafitinib _LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pravastatin (sodium)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pravastatin (sodium)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pentamidine (isethionate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pentamidine (isethionate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Flumatinib (mesylate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Flumatinib (mesylate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Omeprazole (sodium)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Omeprazole (sodium)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Docetaxel (Trihydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Docetaxel (Trihydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Nafamostat (mesylate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Nafamostat (mesylate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_A-427 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_A-427 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_MIA PaCa-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_MIA PaCa-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_PANC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_PANC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_C-33 A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_C-33 A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_HCT15 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_HCT15 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_SHP-77 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_SHP-77 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
CYSTEAMINE HYDROCHLORIDE Gene Set From DGIdb Drug Targets 2026 interacting proteins for the CYSTEAMINE HYDROCHLORIDE drug from theDGIdb Drug Targets 2026 dataset.
Cysteamine Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical Cysteamine from the curated CTD Gene-Chemical Interactions dataset.
Cysteamine Gene Set From DrugBank Drug Targets interacting proteins for the Cysteamine drug from the curated DrugBank Drug Targets dataset.
cysteamine Gene Set From GeneRIF Biological Term Annotations genes co-occuring with the biological term cysteamine in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
cysteamine dioxygenase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the cysteamine dioxygenase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
Cysteamine Gene Set From HMDB Metabolites of Enzymes interacting proteins for the Cysteamine metabolite from the curated HMDB Metabolites of Enzymes dataset.
Cysteamine dioxygenase Gene Set From InterPro Predicted Protein Domain Annotations proteins predicted to have the Cysteamine dioxygenase protein domain from the InterPro Predicted Protein Domain Annotations dataset.
cysteamine dioxygenase activity Gene Set From GO Molecular Function Annotations 2023 genes performing the cysteamine dioxygenase activity molecular function from the curated GO Molecular Function Annotations 2023 dataset.
Cysteamine Gene Set From MW Enzyme Metabolite Associations interacting proteins for Cysteamine metabolite from the MW Gene Metabolite Associations dataset.
cysteamine dioxygenase activity Gene Set From GO Molecular Function Annotations 2025 genes performing the cysteamine dioxygenase activity molecular function from the curated GO Molecular Function Annotations 2025 dataset.
KYSE-180 Gene Set From COSMIC Cell Line Gene CNV Profiles genes with high or low copy number in KYSE-180 relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
ME-180 Gene Set From COSMIC Cell Line Gene CNV Profiles genes with high or low copy number in ME-180 relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
LS-180 Gene Set From COSMIC Cell Line Gene CNV Profiles genes with high or low copy number in LS-180 relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
KYSE-180 Gene Set From COSMIC Cell Line Gene Mutation Profiles genes mutated in the KYSE-180 cell line from the COSMIC Cell Line Gene Mutation Profiles dataset.
LS-180 Gene Set From COSMIC Cell Line Gene Mutation Profiles genes mutated in the LS-180 cell line from the COSMIC Cell Line Gene Mutation Profiles dataset.
ME-180 Gene Set From COSMIC Cell Line Gene Mutation Profiles genes mutated in the ME-180 cell line from the COSMIC Cell Line Gene Mutation Profiles dataset.
F-180 vasoconstrictor peptide Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical F-180 vasoconstrictor peptide from the curated CTD Gene-Chemical Interactions dataset.
PCB 180 Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical PCB 180 from the curated CTD Gene-Chemical Interactions dataset.
ME-180 Gene Set From GDSC Cell Line Gene Expression Profiles genes with high or low expression in ME-180 relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
hair shafts flattened at irregular intervals and twisted through 180 degrees about their axes Gene Set From HPO Gene-Disease Associations genes associated with the hair shafts flattened at irregular intervals and twisted through 180 degrees about their axes phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.
KYSE-180 Gene Set From Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles genes with high or low copy number in KYSE-180 relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
ME-180 Gene Set From Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles genes with high or low copy number in ME-180 relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
LS 180 Gene Set From Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles genes with high or low copy number in LS 180 relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
KYSE-180 Gene Set From Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles genes with high or low expression in KYSE-180 relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
ME-180 Gene Set From Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles genes with high or low expression in ME-180 relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
LS 180 Gene Set From Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles genes with high or low expression in LS 180 relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
KYSE-180 Gene Set From Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles genes mutated in the KYSE-180 cell line from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset.
ME-180 Gene Set From Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles genes mutated in the ME-180 cell line from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset.
LS 180 Gene Set From Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles genes mutated in the LS 180 cell line from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset.
ls-180 cell Gene Set From TISSUES Text-mining Tissue Protein Expression Evidence Scores proteins co-occuring with the tissue ls-180 cell in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
s-180 cell Gene Set From TISSUES Text-mining Tissue Protein Expression Evidence Scores proteins co-occuring with the tissue s-180 cell in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
KYSE-180 Gene Set From Sanger Dependency Map Cancer Cell Line Proteomics proteins associated with the cell line KYSE-180 from the Sanger Dependency Map Cancer Cell Line Proteomics dataset.
LS-180 Gene Set From Sanger Dependency Map Cancer Cell Line Proteomics proteins associated with the cell line LS-180 from the Sanger Dependency Map Cancer Cell Line Proteomics dataset.
ME-180 Gene Set From Sanger Dependency Map Cancer Cell Line Proteomics proteins associated with the cell line ME-180 from the Sanger Dependency Map Cancer Cell Line Proteomics dataset.
Sarcoma 180 Gene Set From DisGeNET Gene-Disease Associations genes associated with the disease Sarcoma 180 in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
Hair Shafts Flattened At Irregular Intervals And Twisted Through 180 Degrees About Their Axes Gene Set From DisGeNET Gene-Disease Associations genes associated with the disease Hair Shafts Flattened At Irregular Intervals And Twisted Through 180 Degrees About Their Axes in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
Brain_CT2_CA13 180 Gene Set From HuBMAP ASCT+B Annotations biomarker genes for the Brain_CT2_CA13 180 cell type from the HuBMAP ASCT+B dataset.
Brain_CT2_CA13 180 Gene Set From HuBMAP ASCT+B Augmented with RNA-seq Coexpression biomarker genes for the Brain_CT2_CA13 180 cell type from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset.
LS-180 cell Gene Set From TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 proteins co-occuring with the tissue LS-180 cell in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
S-180 cell Gene Set From TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 proteins co-occuring with the tissue S-180 cell in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
Dihydroartemisinin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dihydroartemisinin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
ML264_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the ML264_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Hydroxyfasudil_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Hydroxyfasudil_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Elagolix sodium_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Elagolix sodium_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Piroxicam_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Piroxicam_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Medroxyprogesterone acetate_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Medroxyprogesterone acetate_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pimozide_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pimozide_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Mifepristone_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Mifepristone_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bexarotene_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bexarotene_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Triclosan_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Triclosan_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clopidogrel_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clopidogrel_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bicalutamide_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bicalutamide_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rapamycin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rapamycin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Regorafenib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Regorafenib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Posaconazole_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Posaconazole_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Simotinib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Simotinib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lucanthone_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lucanthone_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Isocorydine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Isocorydine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Malotilate_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Malotilate_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Folic acid_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Folic acid_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ciclopirox_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ciclopirox_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Adenosine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Adenosine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
GSK1059615_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the GSK1059615_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Brimonidine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Brimonidine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cilostazol_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cilostazol_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Trifluridine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Trifluridine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
PF-06260933_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the PF-06260933_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Budesonide_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Budesonide_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Hexylresorcinol_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Hexylresorcinol_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Verteporfin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Verteporfin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Temsirolimus_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Temsirolimus_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
AZD1390_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the AZD1390_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
ETC-206_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the ETC-206_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Relugolix_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Relugolix_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivermectin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivermectin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dexamethasone_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dexamethasone_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ponatinib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ponatinib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Proglumide_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Proglumide_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tofacitinib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vitamin K4_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vitamin K4_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idoxuridine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idoxuridine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vortioxetine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vortioxetine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Amsacrine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Amsacrine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Megestrol_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Megestrol_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
crizotinib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the crizotinib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Trimetrexate_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Trimetrexate_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cepharanthine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cepharanthine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
DTP3_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the DTP3_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Thymol_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Thymol_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Retinoic acid_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Retinoic acid_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berbamine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berbamine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Filgotinib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Filgotinib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Mozavaptan_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Mozavaptan_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fumaric acid_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fumaric acid_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Finasteride_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Finasteride_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Acetohexamide_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Acetohexamide_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Zileuton_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Zileuton_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Macitentan_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Macitentan_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ranolazine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ranolazine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Decitabine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Decitabine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dimethyl fumarate_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dimethyl fumarate_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Larotrectinib sulfate_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Larotrectinib sulfate_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methylthiouracil_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methylthiouracil_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pentoxifylline_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pentoxifylline_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dexmedetomidine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dexmedetomidine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Gemcitabine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Gemcitabine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Valdecoxib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Valdecoxib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbamazepine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbamazepine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Resveratrol_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Resveratrol_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Uridine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Uridine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
AZD-8055_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the AZD-8055_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Diphenhydramine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Diphenhydramine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sulfisoxazole_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sulfisoxazole_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Drospirenone_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Drospirenone_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Raltitrexed_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Raltitrexed_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entrectinib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entrectinib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Oleic acid_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Oleic acid_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tolcapone_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tolcapone_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Voriconazole_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Voriconazole_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
palbociclib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the palbociclib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Terfenadine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Terfenadine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Artesunate_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Artesunate_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Riluzole hydrochloride_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Riluzole hydrochloride_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bortezomib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bortezomib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clobetasol propionate_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clobetasol propionate_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Abemaciclib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Abemaciclib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Monocrotaline_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Monocrotaline_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ixazomib citrate_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ixazomib citrate_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Orlistat_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Orlistat_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Encorafenib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Encorafenib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Binimetinib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Binimetinib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Demeclocycline_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Demeclocycline_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Futibatinib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Futibatinib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Oxaliplatin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Oxaliplatin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
8-Hydroxyquinoline_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the 8-Hydroxyquinoline_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Meloxicam_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Meloxicam_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pimitespib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pimitespib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tucidinostat_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tucidinostat_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bimatoprost_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bimatoprost_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Homoharringtonine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Homoharringtonine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
vincristine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the vincristine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Capmatinib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Capmatinib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cyclosporin A_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cyclosporin A_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dinaciclib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dinaciclib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
AZD2858_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the AZD2858_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fulvestrant_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fulvestrant_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Thymopentin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Thymopentin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
olaparib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the olaparib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Celecoxib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Celecoxib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tazarotene_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tazarotene_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ornidazole_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ornidazole_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Eplerenone_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Eplerenone_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Abiraterone acetate_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Abiraterone acetate_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lipoic acid_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lipoic acid_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pemetrexed_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pemetrexed_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
LY2090314_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the LY2090314_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Arbutin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Arbutin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Belinostat_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Belinostat_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(S)-Crizotinib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (S)-Crizotinib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Larotrectinib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Larotrectinib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Aspirin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Aspirin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sunitinib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sunitinib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vismodegib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vismodegib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
SBI-0640756_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the SBI-0640756_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bimiralisib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bimiralisib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
HI-TOPK-032_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the HI-TOPK-032_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Flutamide_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Flutamide_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Anastrozole_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Anastrozole_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Peretinoin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Peretinoin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
IQ 1_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the IQ 1_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
MK-8353_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the MK-8353_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
XRK3F2_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the XRK3F2_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pentagastrin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pentagastrin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Mebendazole_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Mebendazole_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tubulin inhibitor 6_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tubulin inhibitor 6_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Daptomycin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Daptomycin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
ULK-101_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the ULK-101_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Harringtonine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Harringtonine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Gallic acid_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Gallic acid_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Darinaparsin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Darinaparsin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Allantoin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Allantoin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Belzutifan_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Belzutifan_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Adenine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Adenine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
NVP-BHG712_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the NVP-BHG712_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tomivosertib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tomivosertib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Trametinib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Trametinib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
BAY1125976_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the BAY1125976_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Brivudine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Brivudine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ribociclib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ribociclib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Anethole trithione_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Anethole trithione_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Minodronic acid_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Minodronic acid_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Verapamil_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Verapamil_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fluvoxamine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fluvoxamine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dabrafenib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dabrafenib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Panobinostat_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Panobinostat_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Belumosudil_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Belumosudil_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Canagliflozin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Canagliflozin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Olanzapine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Olanzapine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tadalafil_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tadalafil_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ataluren_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ataluren_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
c-Kit-IN-1_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the c-Kit-IN-1_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
5-Fluorouracil_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the 5-Fluorouracil_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pemigatinib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pemigatinib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Hesperidin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Hesperidin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tucatinib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tucatinib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Capivasertib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Capivasertib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Altretamine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Altretamine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Econazole_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Econazole_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Penfluridol_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Penfluridol_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sulfatinib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sulfatinib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Roxadustat_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Roxadustat_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ligustrazine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ligustrazine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Glycyrrhizic acid_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Glycyrrhizic acid_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Digitoxin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Digitoxin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Neratinib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Neratinib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Nevirapine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Nevirapine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Asciminib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Asciminib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Aprepitant_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Aprepitant_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cinacalcet_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cinacalcet_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Afatinib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Afatinib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fusidic acid_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fusidic acid_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
venetoclax_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the venetoclax_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Elimusertib hydrochloride_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Elimusertib hydrochloride_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methotrexate_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methotrexate_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Adagrasib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Adagrasib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ralimetinib dimesylate_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ralimetinib dimesylate_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Temuterkib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Temuterkib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Alpelisib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Alpelisib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lapatinib ditosylate_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lapatinib ditosylate_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
DT-061_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the DT-061_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
AZD-7648_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the AZD-7648_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
4EGI-1_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the 4EGI-1_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Paclitaxel_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Paclitaxel_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Volasertib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Volasertib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
RMC-6236_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the RMC-6236_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Busulfan_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Busulfan_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lopinavir_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lopinavir_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fenofibrate_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fenofibrate_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Baicalin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Baicalin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rifaximin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rifaximin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Furosemide_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Furosemide_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TAK-733_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the TAK-733_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Glasdegib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Glasdegib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Menadione_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Menadione_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
γ-Oryzanol_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the γ-Oryzanol_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Apalutamide_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Apalutamide_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Silodosin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Silodosin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ferulic acid_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ferulic acid_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Quinestrol_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Quinestrol_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
AT7519_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the AT7519_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
9-ING-41_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the 9-ING-41_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Omeprazole_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Omeprazole_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Darolutamide_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Darolutamide_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Allopurinol_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Allopurinol_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
EX229_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the EX229_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Talc_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Talc_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bergenin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bergenin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
CP21R7_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the CP21R7_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vemurafenib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vemurafenib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pralsetinib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pralsetinib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Torkinib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Torkinib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Gefitinib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Gefitinib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
LB-100_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the LB-100_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
ERK5-IN-2_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the ERK5-IN-2_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sodium Salicylate_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sodium Salicylate_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pioglitazone_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pioglitazone_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Triamcinolone_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Triamcinolone_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ixazomib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ixazomib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lonafarnib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lonafarnib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Artemether_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Artemether_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bentamapimod_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bentamapimod_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Salicylic acid_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Salicylic acid_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Delamanid_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Delamanid_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
PH-797804_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the PH-797804_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ipatasertib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ipatasertib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sinomenine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sinomenine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
BI-78D3_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the BI-78D3_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
NG25_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the NG25_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
MK-3903_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the MK-3903_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Saquinavir_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Saquinavir_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Everolimus_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Everolimus_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
5-Azacytidine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the 5-Azacytidine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Naproxen_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Naproxen_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Trametinib (DMSO_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Trametinib (DMSO_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
LJI308_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the LJI308_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dapagliflozin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dapagliflozin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Plicamycin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Plicamycin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Hydroxyurea_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Hydroxyurea_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methylprednisolone succinate_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methylprednisolone succinate_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cobimetinib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cobimetinib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Betamethasone dipropionate_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Betamethasone dipropionate_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Nimesulide_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Nimesulide_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Aliskiren_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Aliskiren_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
OTS514_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the OTS514_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vilanterol_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vilanterol_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sonidegib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sonidegib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
BI-3406_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the BI-3406_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Gemfibrozil_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Gemfibrozil_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clotrimazole_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clotrimazole_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
18β-Glycyrrhetinic acid_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the 18β-Glycyrrhetinic acid_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Docetaxel_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Docetaxel_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TAK-901_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the TAK-901_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clofarabine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clofarabine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Erlotinib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Erlotinib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Captopril_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Captopril_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rosiglitazone_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rosiglitazone_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bendamustine_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bendamustine_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sildenafil_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sildenafil_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tolmetin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tolmetin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sapanisertib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sapanisertib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vandetanib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vandetanib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
APTO-253_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the APTO-253_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Oxaprozin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Oxaprozin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Daidzin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Daidzin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tranilast_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tranilast_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Radotinib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Radotinib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ritonavir_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ritonavir_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Infigratinib_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Infigratinib_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Diammonium Glycyrrhizinate_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Diammonium Glycyrrhizinate_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Auranofin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Auranofin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Erythromycin_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Erythromycin_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Acetazolamide_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Acetazolamide_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
PMC10243915-uxad037_suppl_supplementary_table_s1b-table_s3b.pdf-180-BHLHA15_BHLHA15 Gene Set From Rummagene Transcription Factor Associations 2026 target genes of the PMC10243915-uxad037_suppl_supplementary_table_s1b-table_s3b.pdf-180-BHLHA15_BHLHA15 transcription factor from the Rummagene Transcription Factor Associations 2026 dataset.
PMC12263605-DataSheet1.pdf-180-PPARA_PPARA Gene Set From Rummagene Transcription Factor Associations 2026 target genes of the PMC12263605-DataSheet1.pdf-180-PPARA_PPARA transcription factor from the Rummagene Transcription Factor Associations 2026 dataset.
hydrastine hydrochloride-7309 Gene Set From CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the hydrastine hydrochloride-7309 small molecule perturbation from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
hydrastine hydrochloride-2889 Gene Set From CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the hydrastine hydrochloride-2889 small molecule perturbation from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
hydrastine hydrochloride-1740 Gene Set From CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the hydrastine hydrochloride-1740 small molecule perturbation from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
hydrastine hydrochloride-6011 Gene Set From CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the hydrastine hydrochloride-6011 small molecule perturbation from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
temocapril hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical temocapril hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
4-((2-(1-methyl-2-pyrrolidinyl)ethyl)thio)phenol hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical 4-((2-(1-methyl-2-pyrrolidinyl)ethyl)thio)phenol hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
adrogolide hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical adrogolide hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
2-(5-benzo(1,3)dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical 2-(5-benzo(1,3)dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
Tiapamil Hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical Tiapamil Hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
4-amino-1-(6-chloro-2-pyridyl)piperidine hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical 4-amino-1-(6-chloro-2-pyridyl)piperidine hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical 5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
6,7-dimethyl-2-(2E)-3-(1-methyl-2-phenyl-1H-pyrrolo(2,3-b)pyridin-3-yl-prop-2-enoyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical 6,7-dimethyl-2-(2E)-3-(1-methyl-2-phenyl-1H-pyrrolo(2,3-b)pyridin-3-yl-prop-2-enoyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
(5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical (5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
2-aminomethyl-2-tricyclo(3.3.1.1(1,7))decaneacetic acid hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical 2-aminomethyl-2-tricyclo(3.3.1.1(1,7))decaneacetic acid hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
1-((4-fluorobenzoylamino)ethyl)-4-(7-methoxy-1-naphthyl)piperazine hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical 1-((4-fluorobenzoylamino)ethyl)-4-(7-methoxy-1-naphthyl)piperazine hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE Gene Set From DrugBank Drug Targets interacting proteins for the N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE drug from the curated DrugBank Drug Targets dataset.
betaxolol hydrochloride efficacy Gene Set From GAD Gene-Disease Associations genes associated with the disease betaxolol hydrochloride efficacy in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
hydrochloride Gene Set From GeneRIF Biological Term Annotations genes co-occuring with the biological term hydrochloride in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
Serum tamsulosin hydrochloride concentration Gene Set From GWAS Catalog SNP-Phenotype Associations genes associated with the Serum tamsulosin hydrochloride concentration phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset.
BRD-M73371355_R(-) Apomorphine hydrochloride hemihydrate_MCF7_6.0_h_10.0_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-M73371355_R(-) Apomorphine hydrochloride hemihydrate_MCF7_6.0_h_10.0_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_VCAP_24.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_VCAP_24.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HT29_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HT29_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_VCAP_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_VCAP_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_RMUGS_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_RMUGS_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-K08547377_Irinotecan hydrochloride trihydrate_MCF7_6.0_h_10.0_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-K08547377_Irinotecan hydrochloride trihydrate_MCF7_6.0_h_10.0_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_PC3_24.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_PC3_24.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_PL21_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_PL21_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_SW620_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_SW620_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-K08547377_Irinotecan hydrochloride trihydrate_MCF7_24.0_h_10.0_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-K08547377_Irinotecan hydrochloride trihydrate_MCF7_24.0_h_10.0_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_U937_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_U937_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-K99257182_Quinidine hydrochloride monohydrate_MCF7_6.0_h_10.0_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-K99257182_Quinidine hydrochloride monohydrate_MCF7_6.0_h_10.0_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-K08547377_Irinotecan hydrochloride trihydrate_PC3_24.0_h_10.0_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-K08547377_Irinotecan hydrochloride trihydrate_PC3_24.0_h_10.0_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HCC15_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HCC15_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HCC515_24.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HCC515_24.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_NCIH2073_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_NCIH2073_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_OV7_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_OV7_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A549_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A549_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_WSUDLCL2_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_WSUDLCL2_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_MCF7_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_MCF7_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_JHUEM2_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_JHUEM2_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-K47448802_ethyl 4-(2-benzamidoethylamino)piperidine-1-carboxylate hydrochloride Vanderbilt_Probe_3_HEPG2_6.0_h_10.0_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-K47448802_ethyl 4-(2-benzamidoethylamino)piperidine-1-carboxylate hydrochloride Vanderbilt_Probe_3_HEPG2_6.0_h_10.0_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-K69231968_ethyl 4-(2-(3,4-difluorobenzamido)ethylamino)piperidine-1-carboxylate hydrochloride Vanderbilt_Probe_6_VCAP_24.0_h_10.0_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-K69231968_ethyl 4-(2-(3,4-difluorobenzamido)ethylamino)piperidine-1-carboxylate hydrochloride Vanderbilt_Probe_6_VCAP_24.0_h_10.0_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A549_24.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A549_24.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HEPG2_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HEPG2_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_MCF7_24.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_MCF7_24.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HCC515_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HCC515_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_SKMEL1_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_SKMEL1_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A375_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A375_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_DV90_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_DV90_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_NCIH596_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_NCIH596_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HT29_24.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HT29_24.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HA1E_24.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HA1E_24.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_MDST8_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_MDST8_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HCT116_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HCT116_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HA1E_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HA1E_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_SKM1_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_SKM1_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_LOVO_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_LOVO_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_AGS_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_AGS_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A375_24.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A375_24.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A673_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A673_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_SKLU1_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_SKLU1_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BCI-hydrochloride Gene Set From LINCS L1000 CMAP Chemical Perturbation Consensus Signatures genes differentially expressed following the BCI-hydrochloride small molecule perturbation from the LINCS L1000 CMAP Chemical Perturbation Consensus Signatures dataset.
Doxorubicin (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_MIA PaCa-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_MIA PaCa-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_MIA PaCa-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_MIA PaCa-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_A-427 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_A-427 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_SHP-77 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_SHP-77 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_HCT15 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_HCT15 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_A-427 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_A-427 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_SHP-77 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_SHP-77 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_MIA PaCa-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_MIA PaCa-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_HCT15 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_HCT15 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_PANC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_PANC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_PANC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_PANC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.

Harmonizome 3.0

ADO Gene

Cysteamine (hydrochloride)_LS 180 Gene Set

Norepinephrine (hydrochloride)_LS 180 Gene Set

Topotecan (hydrochloride)_LS 180 Gene Set

Procainamide (hydrochloride)_LS 180 Gene Set

Tetracycline (hydrochloride)_LS 180 Gene Set

Esmolol (hydrochloride)_LS 180 Gene Set

Fingolimod (hydrochloride)_LS 180 Gene Set

Crizotinib (hydrochloride)_LS 180 Gene Set

Ivabradine (hydrochloride)_LS 180 Gene Set

Fedratinib (hydrochloride hydrate)_LS 180 Gene Set

Pyridoxine (hydrochloride)_LS 180 Gene Set

Lidocaine (hydrochloride)_LS 180 Gene Set

Idarubicin (hydrochloride)_LS 180 Gene Set

Methyl aminolevulinate (hydrochloride)_LS 180 Gene Set

Epirubicin (hydrochloride)_LS 180 Gene Set

Levobupivacaine (hydrochloride)_LS 180 Gene Set

(R)-Verapamil (hydrochloride)_LS 180 Gene Set

Cytarabine (hydrochloride)_LS 180 Gene Set

Ropivacaine (hydrochloride monohydrate)_LS 180 Gene Set

Clonidine (hydrochloride)_LS 180 Gene Set

Dorzolamide (hydrochloride)_LS 180 Gene Set

Irinotecan (hydrochloride)_LS 180 Gene Set

Doxorubicin (hydrochloride)_LS 180 Gene Set

Imiquimod (hydrochloride)_LS 180 Gene Set

Tirabrutinib (hydrochloride)_LS 180 Gene Set

Rimonabant (Hydrochloride)_LS 180 Gene Set

Phenylephrine (hydrochloride)_LS 180 Gene Set

Almonertinib (hydrochloride)_LS 180 Gene Set

Pexidartinib (hydrochloride)_LS 180 Gene Set

Loperamide (hydrochloride)_LS 180 Gene Set

Bestatin (hydrochloride)_LS 180 Gene Set

Lactate (calcium)_LS 180 Gene Set

S-Adenosyl-L-methionine (disulfate tosylate)_LS 180 Gene Set

Perindopril (erbumine)_LS 180 Gene Set

Chlorhexidine (diacetate)_LS 180 Gene Set

Estrone sulfate (potassium)_LS 180 Gene Set

Fostamatinib (disodium hexahydrate)_LS 180 Gene Set

Dapagliflozin ((2S)-1,2-propanediol, hydrate)_LS 180 Gene Set

L-Eflornithine (monohydrochloride)_LS 180 Gene Set

Pasireotide (acetate)_LS 180 Gene Set

Phenytoin (sodium)_LS 180 Gene Set

Lenalidomide (hemihydrate)_LS 180 Gene Set

Neratinib (maleate)_LS 180 Gene Set

Berbamine (dihydrochloride)_LS 180 Gene Set

Atazanavir (sulfate)_LS 180 Gene Set

Indacaterol (maleate)_LS 180 Gene Set

Rucaparib (phosphate)_LS 180 Gene Set

Benztropine (mesylate)_LS 180 Gene Set

Tofacitinib (citrate)_LS 180 Gene Set

Canagliflozin (hemihydrate)_LS 180 Gene Set

Pitavastatin (Calcium)_LS 180 Gene Set

Ouabain (Octahydrate)_LS 180 Gene Set

Palmatine (chloride)_LS 180 Gene Set

Quinidine (15% dihydroquinidine)_LS 180 Gene Set

Vinblastine (sulfate)_LS 180 Gene Set

Almonertinib (mesylate)_LS 180 Gene Set

Osimertinib (mesylate)_LS 180 Gene Set

Goserelin (acetate)_LS 180 Gene Set

Lumateperone (tosylate)_LS 180 Gene Set

Azithromycin (hydrate)_LS 180 Gene Set

Benproperine (phosphate)_LS 180 Gene Set

Bisoprolol (hemifumarate)_LS 180 Gene Set

Rutin (trihydrate)_LS 180 Gene Set

Citalopram (hydrobromide)_LS 180 Gene Set

L-Thyroxine (sodium salt pentahydrate)_LS 180 Gene Set

Bosentan (hydrate)_LS 180 Gene Set

Imiquimod (maleate)_LS 180 Gene Set

Selinexor _LS 180 Gene Set

Fluvoxamine (maleate)_LS 180 Gene Set

Doxycycline (monohydrate)_LS 180 Gene Set

Niclosamide (olamine)_LS 180 Gene Set

Gallic acid (hydrate)_LS 180 Gene Set

Belumosudil (mesylate)_LS 180 Gene Set

Cloxacillin (sodium)_LS 180 Gene Set

LY-2584702 (tosylate salt)_LS 180 Gene Set

Sivelestat (sodium tetrahydrate)_LS 180 Gene Set

Berberine (chloride hydrate)_LS 180 Gene Set

Mitoxantrone (dihydrochloride)_LS 180 Gene Set